Mylan (MYL +4.1%) jumps after receiving final FDA approval of its Abbreviated New Drug...

|About: Mylan Inc (MYL)|By:, SA News Editor

Mylan (MYL +4.1%) jumps after receiving final FDA approval of its Abbreviated New Drug Application for its chemoprotective agent Dexrazoxane for injection, a generic version of Pharmacia & Upjohn's Zinecard.